Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Critical Care
When would you be comfortable with using HFNC rather than NIV in patients with acute respiratory failure?
Do the findings of the
RENOVATE
trial influence your approach?
Related Questions
Do you routinely use pupillometry for serial neurologic examinations in the ICU, especially for patients at risk for transtentorial herniation?
Do you recommend treating Candida albicans on urine culture from an indwelling catheter in a patient with septic shock?
Do scores for identification of early sepsis, such as qSOFA, SIRS, or NEWS, hold significance for patients who are already admitted to the ICU?
Are there instances when you recommend initiation of hemodialysis for patients with severe symptomatic hypercalcemia?
What would be your approach to percutaneous intervention for acute plaque rupture and cardiogenic shock for a patient with cirrhosis and severe thrombocytopenia?
What’s your approach to an asymptomatic, hemodynamically stable patient with moderate spontaneous pneumomediastinum without pneumothorax and normal esophagogram?
Do you consider thrombocytopenia a contraindication for fibrinolytic therapy for a massive PE?
Do you use or recommend clinical severity scores or other parameters in helping prognostication in patients with refractory status epilepticus?
Do you maintain a strict platelet threshold of >50k when performing a lumbar puncture, or are there situations in which you feel comfortable with a lower threshold?
Would you start octreotide in a patient with suspected sulfonyurea overdose but without frank hypoglycemia?